* Liten Q1e: +10 % intäktstillväxt, EBITDA på DKK -3,2m* Tyska utrullningar enligt plan; vi ligger k...
AVTECH's Q1 2026 key figures, published ahead of the full report on 24 April, revealed a sequential ...
Vi lämnar våra prognoser i stort sett oförändrade inför Nellys Q1.
We leave our estimates largely unchanged ahead of Nelly’s Q1.
Redeye comments on Initiator Pharma’s announcement that it will discontinue development of IP2018 an...
Steyr Motors reported final 2025 results in line with prelims, confirmed its 2026 guidance and provi...
Following a quiet March, the Top Picks Investment Committee is putting our cash pile to work.
Redeye comments on Avensia’s preliminary sales figures for March 2026, causing a slight increase in ...
Yesterday, NFON published its FY25 annual report, confirming the preliminary figures released in Feb...
Yesterday, MHP released its Q126 hotel performance figures, showing broad-based momentum across the portfolio and confirming the trajectory ...
Coor avslutade 2025 starkt med en tydlig marginalförbättring i Sverige och ökad aktivitet i både Sve...
DT reports Q1 results on Apr 23. It shouldn’t take more than to maintain last year’s rather low EBIT...
Aiforia France has been selected as the sole AI partner for the French government-backed PROSTIA pro...
Redeye anticipates a muted Q1 (due 7 May), as strong growth in user base and premium subscriptions i...
We keep our estimates and fair value range unchanged Ahead of Leaddesk’s Q1 report.
Redeye gives a short comment on today’s news regarding the STK25 program and other newsflow.
Redeye comments on Faron announcing an agreement with Parexel to support the randomized phase IIb BE...
Redeye comments on Sivers’ directed share issue and evaluation of a potential US dual listing, which...
Redeye raises its Base Case for Hexatronic slightly to SEK32 (29), reflecting somewhat greater confi...
Traumautoverlosung brings ZEAL’s proprietary charity-raffle format into the premium car category, wi...